Cara Therapeutics, Inc. (NASDAQ:CARA) Q1 2023 Earnings Call Transcript May 15, 2023
Cara Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.49, expectations were $-0.52.
Operator: Good afternoon. My name is Lateef, and I will be your conference facilitator. I would like to welcome everyone to the Cara Therapeutics First Quarter Financial Results and Update Conference Call. [Operator Instructions] Please be advised that this call is being recorded. I would now like to...
